Milan, Italy

Stefania Bertuolo

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.6

ph-index = 1


Location History:

  • Milan, IT (2021)
  • Milano MI, IT (2021)

Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Stefania Bertuolo: Innovator in Pharmaceutical Synthesis

Introduction

Stefania Bertuolo is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of novel processes and intermediates. With a total of 2 patents, her work is recognized for its impact on the production of active pharmaceutical ingredients.

Latest Patents

Stefania's latest patents include a process for preparing intermediates for the synthesis of optically active beta-amino alcohols by enzymatic reduction. This invention focuses on the enzymatic reduction of beta-amino ketones, leading to the creation of novel synthesis intermediates. These intermediates are crucial for the preparation of active pharmaceutical ingredients, including vilanterol and its salts. Another notable patent involves a process for the preparation of a novel umeclidinium synthesis intermediate. This invention not only introduces a versatile synthesis intermediate but also provides reference standards for detecting impurity traces in umeclidinium preparation.

Career Highlights

Stefania Bertuolo is currently associated with Olon S.p.a., where she continues to innovate in the pharmaceutical sector. Her expertise in enzymatic processes and synthesis intermediates has positioned her as a key player in her field.

Collaborations

Stefania has collaborated with notable colleagues, including Corrado Colli and Giorgio Bertolini. Their combined efforts have further advanced the research and development of pharmaceutical synthesis.

Conclusion

Stefania Bertuolo's contributions to pharmaceutical synthesis through her innovative patents highlight her role as a leading inventor in the industry. Her work continues to influence the development of essential pharmaceutical compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…